XOMA Corporation Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Net Loss Per Share Attributable to Common Stockholders (Tables)

Net Loss Per Share Attributable to Common Stockholders (Tables)

12 Months Ended

Dec. 31, 2023

Net Loss Per Share Attributable to Common Stockholders

Schedule of outstanding securities considered anti-dilutive

The following table shows the weighted-average shares from outstanding securities considered anti-dilutive and therefore excluded from the computation of diluted net loss per share attributable to common stockholders (in thousands):


	Year Ended December 31,
	2023	2022
Convertible preferred stock	5,003	5,003
Common stock options	1,793	885
Warrants for common stock	17	6
Total	6,813	5,894

Schedule of reconciliation of numerator and denominator used in calculation of basic and diluted net loss per share attributable to common stockholders

The following is a reconciliation of the numerator (net loss) and the denominator (number of shares) used in the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share amounts):


	Year Ended December 31,
	2023		2022
Numerator
Net loss	$	(40,831)	$	(17,104)
Less: Series A accumulated dividends		(2,122)		(2,122)
Less: Series B accumulated dividends		(3,350)		(3,350)
Net loss attributable to common stockholders, basic and diluted	$	(46,303)		(22,576)

Denominator
Weighted average shares used in computing basic and diluted net loss per share attributable to common stockholders		11,471		11,413
Basic and diluted net loss per share attributable to common stockholders	$	(4.04)	$	(1.98)